Guided Therapeutics is a developer of rapid and painless test for the early detection of disease that leads to cervical cancer.
The grant provides Guided Therapeutics to complete the regulatory process and begin manufacturing for the device and single-patient-use disposable.
Deal Value (US$ Million) 2.5 Deal Type Partnership Sub-Category Other Deal Status Announced: 2009-10-05
Deal Participants
Partner 1 (Company) The U.S. Department of Health and Human Services Partner 2 (Company) The National Cancer Institute Partner 3 (Company) Guided Therapeutics, Inc. (formerly SpectRx, Inc.) Partner 4 (Company) National Institutes of Health
Deal Rationale
This grant provides significant non-dilutive resources for Guided Therapeutics to begin manufacturing LightTouch devices and disposables for an international launch.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index